Schedule I (Tables)

12 Months Ended

Dec. 31, 2020

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets


(in millions, except per share data)	December 31, 2020		December 31, 2019
Assets
Current assets:
Cash and cash equivalents	$	258	$	46
Other current assets	562		787
Total current assets	820		833
Equity in net assets of subsidiaries	107,714		93,467
Long-term notes receivable from subsidiaries	5,021		5,079
Other assets	342		794
Total assets	$	113,897	$	100,173

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	589	$	688
Current portion of notes payable to subsidiaries	4,882		750
Short-term borrowings and current maturities of long-term debt	4,465		3,548
Total current liabilities	9,936		4,986
Long-term debt, less current maturities	37,815		35,926
Long-term notes payable to subsidiaries	—		1,314
Other liabilities	655		331
Total liabilities	48,406		42,557
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—		—
Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding	10		9
Additional paid-in capital	—		7
Retained earnings	69,295		61,178
Accumulated other comprehensive loss	(3,814)		(3,578)
Total UnitedHealth Group shareholders’ equity	65,491		57,616
Total liabilities and shareholders’ equity	$	113,897	$	100,173

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income


	For the Years Ended December 31,
(in millions)	2020		2019		2018
Revenues:
Investment and other income	$	194	$	209	$	194
Total revenues	194		209		194
Operating costs:
Operating costs	27		38		35
Interest expense	1,594		1,580		1,285
Total operating costs	1,621		1,618		1,320
Loss before income taxes	(1,427)		(1,409)		(1,126)
Benefit for income taxes	300		293		251
Loss of parent company	(1,127)		(1,116)		(875)
Equity in undistributed income of subsidiaries	16,530		14,955		12,861
Net earnings	15,403		13,839		11,986
Other comprehensive (loss) income	(236)		582		(1,517)
Comprehensive income	$	15,167	$	14,421	$	10,469

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows


	For the Years Ended December 31,
(in millions)	2020		2019		2018
Operating activities
Cash flows from operating activities	$	8,842	$	9,275	$	6,099
Investing activities
Issuances of notes to subsidiaries	(628)		(2,722)		(1,420)
Repayments of notes to subsidiaries	1,089		2,249		1,419
Cash paid for acquisitions	(7,706)		(9,645)		(4,066)
Return of capital to parent company	943		4,497		4,196
Capital contributions to subsidiaries	(43)		(803)		(1,259)
Other, net	143		490		4
Cash flows used for investing activities	(6,202)		(5,934)		(1,126)
Financing activities
Common stock repurchases	(4,250)		(5,500)		(4,500)
Proceeds from common stock issuances	1,440		1,037		838
Cash dividends paid	(4,584)		(3,932)		(3,320)
Proceeds from (repayments of) short-term borrowings, net	872		300		(201)
Proceeds from issuance of long-term debt	4,864		5,444		6,935
Repayments of long-term debt	(3,150)		(1,750)		(2,600)
Proceeds (repayments) of notes from subsidiaries	2,818		1,207		(1,127)
Other, net	(438)		(535)		(923)
Cash flows used for financing activities	(2,428)		(3,729)		(4,898)
Increase (decrease) in cash and cash equivalents	212		(388)		75
Cash and cash equivalents, beginning of period	46		434		359
Cash and cash equivalents, end of period	$	258	$	46	$	434

Supplemental cash flow disclosures
Cash paid for interest	$	1,633	$	1,506	$	1,294
Cash paid for income taxes	4,185		2,590		2,379

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows: